You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: January 1, 2025

~ Buy the TALZENNA (talazoparib tosylate) Drug Profile, 2024 PDF Report in the Report Store ~

CLINICAL TRIALS PROFILE FOR TALZENNA


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for TALZENNA

Showing 1 to 3 of 3 entries

Clinical Trial Conditions for TALZENNA

Condition Name

64200123456Breast CancerTriple Negative Breast CancerRecurrent Malignant Solid Neoplasm[disabled in preview]
Condition Name for TALZENNA
Intervention Trials
Breast Cancer 6
Triple Negative Breast Cancer 4
Recurrent Malignant Solid Neoplasm 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

753001234567Breast NeoplasmsTriple Negative Breast NeoplasmsNeoplasms[disabled in preview]
Condition MeSH for TALZENNA
Intervention Trials
Breast Neoplasms 7
Triple Negative Breast Neoplasms 5
Neoplasms 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for TALZENNA

Trials by Country

+
Trials by Country for TALZENNA
Location Trials
United States 109
Canada 2
Spain 1
Denmark 1
Poland 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

+
Trials by US State for TALZENNA
Location Trials
Texas 8
New York 6
Massachusetts 6
Georgia 5
California 5
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for TALZENNA

Clinical Trial Phase

39.1%34.8%26.1%00123456789Phase 2Phase 1/Phase 2Phase 1[disabled in preview]
Clinical Trial Phase for TALZENNA
Clinical Trial Phase Trials
Phase 2 9
Phase 1/Phase 2 8
Phase 1 6
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

81.8%9.1%9.1%0024681012141618RecruitingNot yet recruitingTerminated[disabled in preview]
Clinical Trial Status for TALZENNA
Clinical Trial Phase Trials
Recruiting 18
Not yet recruiting 2
Terminated 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for TALZENNA

Sponsor Name

trials0246810121416PfizerGenentech, Inc.National Cancer Institute (NCI)[disabled in preview]
Sponsor Name for TALZENNA
Sponsor Trials
Pfizer 16
Genentech, Inc. 4
National Cancer Institute (NCI) 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

57.1%38.6%00510152025303540IndustryOtherNIH[disabled in preview]
Sponsor Type for TALZENNA
Sponsor Trials
Industry 40
Other 27
NIH 3
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.